Cargando…

Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19

INTRODUCTION: Among patients with coronavirus disease 2019 (COVID-19), the factors that affect anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody production remain unclear. This study aimed to identify such factors among patients convalescing from COVID-19. METHODS: This stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kutsuna, Satoshi, Asai, Yusuke, Matsunaga, Akihiro, Kinoshita, Noriko, Terada, Mari, Miyazato, Yusuke, Nakamoto, Takato, Suzuki, Tetsuya, Saito, Sho, Endo, Mio, Kanda, Kohei, Kenji, Maeda, Takasaki, Jin, Hojo, Masayuki, Ishizaka, Yukihito, Ohmagari, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836855/ https://www.ncbi.nlm.nih.gov/pubmed/33531292 http://dx.doi.org/10.1016/j.jiac.2021.01.006

Ejemplares similares

No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity
por: Nomoto, Hidetoshi, et al.
Publicado: (2021)

Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved
por: Suzuki, Tetsuya, et al.
Publicado: (2023)

Hemoptysis and a Newly Formed Lung Bulla in a Case of Convalescent COVID-19 Pneumonia
por: Sato, Lubna, et al.
Publicado: (2021)

Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan
por: Suzuki, Tetsuya, et al.
Publicado: (2022)

Neutralization activity of IgG antibody in COVID‑19‑convalescent plasma against SARS-CoV-2 variants
por: Tsuchiya, Kiyoto, et al.
Publicado: (2023)

Residual and Late Onset Symptoms Appeared in a Patient with Severe Fever with Thrombocytopenia in a Convalescence Stage
por: Kanda, Kohei, et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma
por: Maeda, Kenji, et al.
Publicado: (2021)

Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma
por: Inada, Makoto, et al.
Publicado: (2023)

Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC(50)) of neutralizing antibodies
por: Inada, Makoto, et al.
Publicado: (2021)

Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection
por: Inada, Makoto, et al.
Publicado: (2022)

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan
por: Terada, Mari, et al.
Publicado: (2021)

Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers
por: Katagiri, Daisuke, et al.
Publicado: (2020)

Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine
por: Miyazato, Yusuke, et al.
Publicado: (2022)

Efficacy and Safety of Treatment with Plasma from COVID-19-Recovered Individuals
por: Terada, Mari, et al.
Publicado: (2023)

223. Difference in Carbapenem Use by ASP Intervention in Japanese Healthcare Facilities
por: Endo, Mio, et al.
Publicado: (2020)

908. Evaluation of Blood Culture Submission Rates in Japan
por: Tajima, Taichi, et al.
Publicado: (2020)

Environmental surface and air contamination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severity
por: Nakamura, Keiji, et al.
Publicado: (2020)

Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital
por: Morioka, Shinichiro, et al.
Publicado: (2020)

A nationwide prospective cohort study on safety of the 17D-204 yellow fever vaccine during a vaccine shortage in Japan
por: Miyazato, Yusuke, et al.
Publicado: (2022)

Temporal trends in microbial detection during the COVID-19 pandemic: Analysis of the Japan surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) database
por: Endo, Akira, et al.
Publicado: (2023)

Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019
por: Miyazato, Yusuke, et al.
Publicado: (2020)

Considerations and concerns regarding the readiness to remove face coverings
por: Terada, Mari, et al.
Publicado: (2022)

Clinical course of alopecia after COVID-19
por: Suzuki, Tetsuya, et al.
Publicado: (2021)

First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics
por: Saito, Sho, et al.
Publicado: (2021)

Effect of evacuation of Japanese residents from Wuhan, China, on preventing transmission of novel coronavirus infection: A modelling study
por: Asai, Yusuke, et al.
Publicado: (2021)

Factors associated with development and persistence of post-COVID conditions: A cross-sectional study()
por: Miyazato, Yusuke, et al.
Publicado: (2022)

Comparison of the clinical characteristics and outcomes of Japanese patients with COVID-19 treated in primary, secondary, and tertiary care facilities
por: Tomidokoro, Daiki, et al.
Publicado: (2023)

1182. Risk Factors for the Acquisition of IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan: A Matched Case–control Study
por: Saito, Sho, et al.
Publicado: (2018)

1193. Comparison of the Clinical Outcomes of Patients With IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenem-Sensitive Enterobacteriaceae in Japan
por: Saito, Sho, et al.
Publicado: (2018)

Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers()
por: Suzuki, Tetsuya, et al.
Publicado: (2021)

External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan
por: Yamada, Gen, et al.
Publicado: (2021)

Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients
por: Tsuzuki, Shinya, et al.
Publicado: (2022)

Regional trends in the use of steroids and favipiravir for COVID-19 treatment
por: Asai, Yusuke, et al.
Publicado: (2023)

1147. Regional Trends in Favipiravir and Steroid Use in the Treatment of COVID-19
por: Asai, Yusuke, et al.
Publicado: (2022)

Extracorporeal membrane oxygenation may decrease the plasma concentration of remdesivir in a patient with severe coronavirus disease 2019
por: Ide, Satoshi, et al.
Publicado: (2021)

Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-center, Observational Study in Tokyo, Japan
por: Akiyama, Yutaro, et al.
Publicado: (2020)

Detection of SARS-CoV-2 in Hemodialysis Effluent of Patient with COVID-19 Pneumonia, Japan
por: Okuhama, Ayako, et al.
Publicado: (2020)

Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus disease
por: Okuhama, Ayako, et al.
Publicado: (2022)

Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccination
por: Okumura, Nobumasa, et al.
Publicado: (2022)

Acute portal vein thrombosis with COVID-19 and cirrhosis
por: Miyazato, Yusuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d4smf40dosp8jno1ud7hvh1e4s